Skip to main content
Have a personal or library account? Click to login
Stimuli responsive polymeric nanoparticles in regulated drug delivery for cancer Cover

Stimuli responsive polymeric nanoparticles in regulated drug delivery for cancer

Open Access
|Apr 2012

References

  1. Johnson, B. F. G. (2003). Topics in Catalysis,24(1-4), 147-159. DOI: 10.1023/B:TOCA.0000003086.83434.b6.
  2. Khanna, V. K. (2008). Nanoparticle-based Sensors,58(5), 608-616.
  3. Hoshino, A., Fujioka, K. & Oku, T. (2004). Physicochemical properties and cellular toxicity of nanocrystal quantum dots depend on their surface modification.4(11), 2163-2169. DOI: 10.1021/nl048715d.
  4. Torchilin, V. P. (2001). Structure and design of polymeric surfactant-based drug delivery systems,73(2-3), 137-172. DOI:10.1016/S0168-3659(01)00299-1.
  5. Connor, E. E., Mwamuka, J., Gole, A., Murphy, C. J. & Wyatt, M. D. (2005). Gold nanoparticles are taken up by human cells but do not cause acute cytotoxicity.1(3), 325-327. DOI: 10.1002/smll.200400093.
  6. Wu, X. Y. & Lee, P. I. (1993). Preparation and characterization of thermal and pH sensitive nanospheres.10(10), 1544-1547. DOI: 10.1023/A:1018900114881.
  7. Huang, M., Khor, E. & Lim, L. Y. (2004). Uptake and cytotoxicity of chitosan molecules and nanoparticles: effects of molecular weight and degree of deacetylation.21:344-353. DOI: 10.1023/B:PHAM.0000016249.52831.a5.
  8. Kabanov, A. V. & Alakhov, V. Y. (2002). Pluronic block copolymers in drug delivery: From micellar nanocontainers to biological response modifiers.19(1), 1-72.
  9. Chavanpatil, M. D., Patil, Y. & Panyam, J. (2006). Susceptibility of nanoparticle-encapsulated paclitaxel to p-glycoprotein-mediated drug efflux.320, 150-156. DOI:10.1016/j.ijpharm.2006.03.045.
  10. Pettit, D. K. & Gombotz, W. R. (1998). The development of site-specific drug-delivery systems for protein and peptide biopharmaceuticals,16(8), 343-349. DOI:10.1016/S0167-7799(98)01186-X.
  11. Bellocq, N. C., Pun, S. H., Jensen, G. S. & Davis, M. E. (2003). Transferrin-containing, cyclodextrin polymer-based particles for tumor-targeted gene delivery.14(6), 1122-1132. DOI: 10.1021/bc034125f.
  12. Feng, S. S. (2004). Nanoparticles of biodegradable polymers for new-concept chemotherapy,1(1), 115-125. DOI:10.1586/17434440.1.1.115.
  13. Qiao, W., Wang, B., Wang, Y., Yang, L., Zhang, Y. & Shao, P. (2010). Cancer Therapy Based on Nanomaterials and Nanocarrier Systems,Article ID 796303, 9. DOI:10.1155/2010/796303.
  14. Sona, P. S. (2010). Nanoparticulate Drug Delivery Systems for the Treatment of Diabetes,5(2), 411-418.
  15. Vlerken, L. E. V. & Amiji, M. M. (2006). Multi-functional polymeric nanoparticles for tumor-targeted drug delivery.3(2), 205-16. DOI:10.1517/17425247.3.2.205.
  16. Avgoustakis, K. (2004). Pegylated poly (lactide) and poly (lactide-co-glycolide) nanoparticles: preparation, properties and possible application in drug delivery,1(4), 321-333. DOI: 10.2174/1567201043334605.
  17. Yam, F., Wu, X. Y. & Zhang, Q. (2000). A novel composite membrane for temperature and pH responsive permeation, in: Controlled Drug Delivery: Designing Technology for the Future (263-272). Ed K. Park,
  18. Senior, J. & Gregoriadis, G. (1982). Is half-life of circulating small unilamellar liposomes determined by changes in their permeability?145(1), 109-114. DOI. org/10.1016/0014-5793(82)81216-7.
  19. Shenoy, D., Fu, W., Li, J., Crasto, C., Jones, G., Dimarzio, C., Sridhar, S. & Amiji, M. (2006). Surface functionalization of gold nanoparticles using hetero-bifunctional poly (ethylene glycol) spacer for intracellular tracking and delivery,1(1), 51-57. DOI: 10.2147/nano.2006.1.1.51.
  20. Edward, T. & Yeop, S. J. (2002). U. S. Patent No. 20,070,190,160. Washington, D. C.: U. S. Patent and Trademark Office.
  21. Yin, H., Lee, E. S., Kim, D., Lee, K. H., Oh, K. T. & Bae, Y. H. (2008). Physicochemical characteristics of pH-sensitive poly (L-Histidine)-b-poly (ethylene glycol) / poly (L-lactic acid)-b-poly (ethylene glycol) mixed micelles,126(2), 130-138. DOI:10.1016/j.jconrel.2007.11.014.
  22. Yoshida, R., Kaneko, Y., Sakai, K., Okano, T., Sakurai, Y., Bae, Y. H. & Kim, S. W. (1994). Positive thermosensitive pulsatile drug release using negative thermosensitive hydrogels,32(1), 97-102. DOI:10.1016/0168-3659(94)90229-1.
  23. Seymour, L. W., Duncan, R., Strohalm, J. & Kopecek, J. (1987). Effect of molecular weight (MW) of N-(2-hydroxypropyl) methacrylamide copolymers on body distribution and rate of excretion after subcutaneous, intraperitoneal, and intravenous administration to rats,21(11), 1341-1358. DOI: 10.1002/jbm.820211106.
  24. Shefer, S. & Shefer, A. (2004). U. S. Patent No. 20,040,062,778. Washington, D. C.: U. S. Patent and Trademark Office.
  25. Yang, T. H. (2008). Recent Applications of Polyacrylamide as Biomaterials,1(1), 29-40. DOI: 10.2174/1874465610801010029.
  26. Yong, L. I. Y., Qing, D. H., Kang, W., DongLu, S. H. I., Zheng, Z. X. & Xi, Z. R. (2010). Stimulus-responsive polymeric Nanoparticles for biomedical applications,53(3), 447-457. DOI: 10.1007/s11426-010-0101-4.
  27. Song, M., Guo, D., Pan, C., Jiang, H., Chen, C., Zhang, R., Gu, Z. & Wang, X. (2008). The application of poly(N-isopropylacrylamide)-co-polystyrene nanofibers as an additive agent to facilitate the cellular uptake of an anticancer drug,19(16), 165102. DOI: 10.1088/0957-4484/19/16/165102.
  28. Bromberg, L., Temchenko, M. & Hatton, T. A. (2002). Dually Responsive Microgels from Polyether-Modified Poly (acrylic acid): Swelling and Drug Loading,18(12), 4944-4952. DOI: 10.1021/la011868l.
  29. Izumi, S. & Kunihiko, T. (1985). U. S. Patent No. 4,536,387. Washington, D. C.: U. S. Patent and Trademark Office.
  30. Youwei, Z. & Ming, J. (2006). New approaches to stimuli-responsive polymeric micelles and hollow spheres,1(5), 364-368. DOI: 10.1007/s11458-006-0049-2.
  31. Grodzinski, J. J. (1999). Biomedical application of functional polymers,39, 99-138.
  32. Sung, Y. K. & Kim, S. W. (2000). Advances in biodegradable polymers for drug delivery systems, Korean Poly. J. 8(5), 199-208.
  33. Knoop, R. J. I., Geus, M. D., Habraken, G. J. M., Koning, C. M., Menzel, H. & Heise, A. (2010). Stimuli Responsive Peptide Conjugated Polymer Nanoparticles,43(9), 4126-4132. DOI: 10.1021/ma100327p.
  34. Wei, H., Zhang, X. Z., Zhou, Y., Cheng, S. X. & Zhuo, R. X. (2006). Self-assembled thermoresponsive micelles of poly(N-isopropylacrylamide-b-methyl methacrylate),27(9), 2028-2034. DOI:10.1016/j.biomaterials.2005.09.028.
  35. Yu, W. X. & Frank, Y. (2003). U. S. Patent No. 6565,872. Washington, D. C.: U. S. Patent and Trademark Office.
  36. Wang, J., Cheng, Y. & Xu, T. (2008). Current Patents of Dendrimers and Hyperbranched Polymers in Membranes,1(1), 41-51.
  37. Erathodiyil, N., Reddy, G. R. & Ham, Y. (2007). U. S. Patent No. 20,070,009,441. Washington, D. C.: U. S. Patent and Trademark Office.
  38. Lyer, A. K., Khaled, G., Fang, J & Maeda, H. (2006). Exploiting the enhanced permeability and retention effect for tumor targeting,11(17-18), 812-818. DOI:10.1016/j.drudis.2006.07.005.
  39. Chang, J. S., Chang, K. L. B., Hwang, D. F. & Kong, Z. L. (2007). In vitro cytotoxicity of silica nanoparticles at high concentrations strongly depends on the metabolic activity type of the cell line,41(6), 2064-2068. DOI: 10.1021/es062347t.
  40. Linhardt, J. G., Raiche, A. T. & Salmone, C. (2009). U. S. Patent No. 20,090,117,189. Washington, D. C.: U. S. Patent and Trademark Office.
  41. Zhang, G., Desnoyer J. R., Stewart, G., Kezis, M. & Hossainy, S. F. A. (2008). U. S. Patent No. 20,080,057,024. Washington, D. C.: U. S. Patent and Trademark Office.
  42. West, J. L., Sershen, S, R. & Halas, N. J. (2002). U. S. Patent No. 6,428,811. Washington, D. C.: U. S. Patent and Trademark Office.
  43. Rapoport, N. (2007). Physical stimuli-responsive polymeric micelles for anti-cancer drug delivery,32(8-9), 962-990. DOI:10.1016/j.progpolymsci.2007.05.009.
  44. Hatefi, A. & Amsden, B. (2002). Biodegradable inject able in situ forming drug delivery systems,80(1-3), 9-28. DOI:10.1016/S0168-3659(02)00008-1.
  45. Yin, H., Lee, E. S., Kim, D., Lee, K. H., Oh, K. T. & Bae, Y. H. (2008). Physicochemical characteristics of pH-sensitive poly (l-Histidine)-b-poly (ethylene glycol)/poly (l-Lactide)-b-poly (ethylene glycol) mixed micelles,126(2), 130-138. DOI:10.1016/j.jconrel.2007.11.014.
  46. Ichikawa, H. & Fukumori, Y. (2000). A novel positively thermosensitive controlled release microcapsule with membrane of nano-sized poly (N-isopropylacrylamie) gel ispesed in ethylcellulose matrix,63(1-2), 107-119.
  47. Donald, O., Peppas, E. & Nicholas, A. (2008). U. S. Patent No. 20,080,138,430. Washington, D. C.: U. S. Patent and Trademark Office.
  48. Park, Y. S., Ito, Y. & Imanishi, Y. (1998). Permeation control through porous membranes immobilized with thermosensitive polymer,14(4), 910-914. DOI: 10.1021/la970866r.
  49. Mitra, S., Gaur, U., Ghosh, P. C. & Maitra, A. N. (2001). Tumour Targeted Delivery of Encapsulated Dextran-Doxorubicin Conjugate Using Chitosan Nanoparticles as Carrier.74(1-6), 317-323. DOI: 10.1016/S0168-3659(01)00342-X.
  50. Chen, H. C. & Chatterjee, Y. (2006). U. S. Patent No. 7,081,489. Washington, D. C.: U. S. Patent and Trademark Office.
  51. Singer, J. W., Baker, B., De Vries, P., Kumar, A., Shaffer, S., Vawter, E., Bolton, M. & Garzone, P. (2003). Poly-(L)-glutamic acid-paclitaxel (CT-2103) [XYOTAX (TM)], a biodegradable polymeric drug conjugate—Characterization, preclinical pharmacology, and preliminary clinical data,519, 81-99. DOI: 10.1007/0-306-47932-X_6.
  52. Zhao, M., Zabelina, Y., Rudek, M. A., Wolff, A. C. & Baker, S. D. (2003). A rapid and sensitive method for determination of dimethyl benzoylphenyl urea in human plasma by using LC/MS/MS,33(4), 725-733. DOI:10.1016/S0731-7085(03)00424-2.
  53. Sung & Hsing-Wen. (2006). U. S. Patent No. 20,060,115,537. Washington, D. C.: U. S. Patent and Trademark Office.
  54. Na, K., Lee, K. H., Lee, D. H. & Bae, Y. H. (2006). Biodegradable thermosensitive nanoparticles from poly(L-lactic acid)/poly(ethylene glycol) alternating multi-block copolymer for potential anti-cancer drug carrier,27(2-3), 115-122. DOI:10.1016/j.ejps.2005.08.012.
  55. Stayton, P. S., Hoffman, S. S. & Xiangchun, Y. (2001). U. S. Patent No. 20,070,224,241. Washington, D. C.: U. S. Patent and Trademark Office.
  56. Chen, D., Jiang, M. & Huisheng, P. (2007). U. S. Patent No. 7,166,306. Washington, D. C.: U. S. Patent and Trademark Office.
  57. Des Rieux, A., Fievez, V., Garinot, M., Schneider, Y. J. & Preat, V. (2006). Nanoparticles as potential oral delivery systems of proteins and vaccines: a mechanistic approach,116(1), 1-27. DOI:10.1016/j.jconrel.2006.08.013.
  58. Ko, J., Park, K., Kim, Y. S., Kim, M. S., Han, J. K., Kim, K., Park, R. W., Kim, I. S., Song, H. K. & Lee, D. S. (2007). Kwon IC. Tumoral acidic extracellular pH targeting of pH-responsive MPEG-poly (beta-amino ester) block copolymer micelles for cancer therapy,123(2), 109-115. DOI:10.1016/j.jconrel.2007.07.012.
  59. Wright, D. C. (1998). U. S. Patent No. 5,795,582. Washington, D. C.: U. S. Patent and Trademark Office.
  60. Dunn, R. L., Garrett, J. S. & Ravivarapu, H. (2004). U. S. Patent No. 6,773,714. Washington, D. C.: U. S. Patent and Trademark Office.
  61. Harada, M., Sakakibara, H., Yano, T., Suzuki, T. & Okuno, S. (2000). Determinants for the Drug Release from T-0128, Camptothecin Analogue-Carboxymethyl Dextran Conjugate,69(3), 399-412. DOI:10.1016/S0168-3659(00)00321-7.
  62. Chen, D. Jiang, M. Peng. & Huisheng. (2007). U. S. Patent No. 7,166,306. Washington, D. C.: U. S. Patent and Trademark Office.
  63. Ulbrich, K. & Subr, V. (2004). Polymeric anticancer drugs with pH-controlled activation,56(7), 1023-1050. DOI:10.1016/j.addr.2003.10.040.
  64. Kramer, M., Stumbe, J. F., Turk, H., Krause, S., Komp, A., Delineau, L., Prokhorova, S., Kautz, H. & Haag, R. (2002). pH-responsive molecular nanocarriers based on dendritic core-shell architectures,41(22), 4252-4256. DOI: 10.1002/1521-3773(20021115.
  65. Lee, E. S., Na, K. & Bae, Y. H. (2005). Super pH-sensitive multifunctional polymeric micelle,5(2), 325-329. DOI: 10.1021/nl0479987.
  66. Little, S. R., Lynn, D. M. & Anderson, D. G. (2005). U. S. Patent No. 20,050,245,049. Washington, D. C.: U. S. Patent and Trademark Office.
  67. Kim, J. J. & Park, K. (2001). Modulated insulin delivery from glucose-sensitive hydrogel dosage forms,77(1-2), 39-47. DOI:10.1016/S0168-3659(01)00447-3.
  68. Lavasanifar, A., Samuel, J. & Kwon, G. S. (2002). Poly (ethylene oxide)-block-poly (L-amino acid) micelles for drug delivery,54(2), 169-190. DOI:10.1016/S0169-409X(02)00015-7.
  69. Lee, I. & Srivastava, D. (2008). U. S. Patent No. 20,080,176,074. Washington, D. C.: U. S. Patent and Trademark Office.
  70. Chen, Mei-chin, T. & Hos1heng. (2008). U. S. Patent No. 20,080,160,078. Washington, D. C.: U. S. Patent and Trademark Office.
  71. Hubbell, J. H., Pathak, C. P. and Sawhney, A. S. (1999). U. S. Patent No. 5,986,043. Washington, D. C.: U. S. Patent and Trademark Office.
  72. Petereit, Hans-ulrich, & Meier. (2005). U. S. Patent No. 20,050,154,165. Washington, D. C.: U. S. Patent and Trademark Office.
  73. Monahan, S. D., Wolff, J. A. and Hagstrom, J. E. (2007). U. S. Patent No. 7,208,314. Washington, D. C.: U. S. Patent and Trademark Office.
  74. Ohya, Y., Oue, H., Nagatomi, K. & Ouchi, T. (2001). Design of Macromolecular Prodrug of Cisplatin Using Dextran with Branched Galactose Units as Targeting Moieties to Hepatoma Cells,, 2(3), 927-933. DOI: http://dx.doi.org/10.1021/bm010053o.
  75. Pendri, A., Conover, C. D. & Greenwald, R. B. (1998). Antitumor activity of paclitaxel-2-glycinate conjugated to poly(ethylene glycol): a water-soluble prodrug,13(5), 387-395.
  76. Rathi, R. C., Zentner, G. M. and Jeong, B. (2000). U. S. Patent No. 20,006,117,949. Washington, D. C.: U. S. Patent and Trademark Office.
  77. Heffernan, M. J. & Murthy, N. (2005). Polyketal nanoparticles: A new pH-sensitive biodegradable drug delivery vehicle,16(6), 1340-1342. DOI: 10.1021/bc050176w.
  78. Sharma, P. C. (2009). U. S. Patent No. 20,090,098,205. Washington, D. C.: U. S. Patent and Trademark Office.
  79. Tomlinson, R., Klee, M., Garrett, S., Heller, S., Duncan, R. & Brocchini, S. (2002). Pendent chain functionalized polyacetals that display pH-dependent degradation: A platform for the development of novel polymer therapeutics,35(2), 473-480. DOI: 10.1021/ma0108867.
  80. Chen, C. J., Haik, Y. & Chatterjee, J. (2006). U. S. Patent No. 7,081,489. Washington, D. C.: U. S. Patent and Trademark Office.
  81. Wenzel, J. G. W., Balaji, K. S. S., Koushik, K., Navarre, C., Duran, S. H., Rahe, C. H. & Kompella, U. B. (2002). Pluronic F127 gelformulations of deslorelin and GnRH reduce drug degradation and sustain drug release and effect in cattle.85, 51-59. DOI:10.1016/S0168-3659(02)00271-7.
  82. Bae, Y. H., Na, K. & Lee (2005). U. S. Patent No. 20,050,186,263. Washington, D. C.: U. S. Patent and Trademark Office.
DOI: https://doi.org/10.2478/v10026-012-0060-y | Journal eISSN: 3072-0389 (formerly 1899-4741) | Journal ISSN: 1509-8117
Language: English
Page range: 57 - 64
Published on: Apr 3, 2012
Published by: West Pomeranian University of Technology, Szczecin
In partnership with: Paradigm Publishing Services
Publication frequency: Volume open

© 2012 Deepak Yadav, Suruchi Suri, Anis Chaudhary, Hemant, Mohd Beg, Veena Garg, Mohd Asif, Altaf Ahmad, published by West Pomeranian University of Technology, Szczecin
This work is licensed under the Creative Commons License.